Additionally, we show that miR-204 acts as a tumor suppressor by regulating Rab40b and Tks5 expression and consequently inhibiting MMP2 and MMP9 targeting, which leads to a decrease in invadopodia-associated ECM degradation. The gene discussed is SH3PXD2A; the disease is neoplasm.